YI LIU: Open Payments
NPI 1598246480 · BELLEVUE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,844 in 70 payments from 17 companies in 2025. Trend: 2023 $1,135 · 2024 $2,245 · 2025 $1,844
Food & beverage: $1,844
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $535 |
| Janssen Biotech, Inc. | 11 | $301 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $172 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $167 |
| Madrigal Pharmaceuticals | 3 | $110 |
| Ipsen Biopharmaceuticals, Inc | 4 | $108 |
| Phathom Pharmaceuticals, Inc. | 6 | $91 |
| Aimmune Therapeutics, Inc. | 3 | $76 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| QOL Medical, LLC | 2 | $49 |
Products named: TREMFYA, XIFAXAN, ENTYVIO, CREON, RINVOQ, LINZESS, REZDIFFRA, VOQUEZNA.
Industry payments across WA — which companies pay providers there.
